Literature DB >> 6154053

Immunological distinction between guanosine 3':5'-monophosphate-dependent and adenosine 3':5'-monophosphate-dependent protein kinases.

U Walter, P Miller, F Wilson, D Menkes, P Greengard.   

Abstract

A guanosine 3':5'-monophosphate (cGMP)-dependent protein kinase was purified from bovine lung using 8-(6-aminohexylamino)-cAMP-Sepharose. The activity of the purified enzyme was highly dependent on cGMP using histone f2b as a substrate. The self-phosphorylation of the purified enzyme was strongly inhibited by cGMP and not significantly affected by cAMP. A precipitating antiserum prepared in rabbits against the cGMP-dependent protein kinase specifically inhibited the histone kinase activity and the self-phosphorylation of the purified cGMP-dependent protein kinase without affecting the cGMP binding site. This antiserum also specifically inhibited the phosphorylation of the endogenous substrate proteins by endogenous cGMP-dependent protein kinase in smooth muscle membranes, but did not cross-react detectably with catalytic subunit or regulatory subunit of type I or type II cAMP-dependent protein kinase. Conversely, anti-sera against the regulatory subunit of type I or type II cAMP-dependent protein kinase did not cross-react detectably with cGMP-dependent protein kinase. The substantial differences between the immunological properties of the cGMP-dependent and cAMP-dependent protein kinases suggest that these two enzymes have distinct physiological roles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells.

Authors:  S Endo; M Suzuki; M Sumi; A C Nairn; R Morita; K Yamakawa; P Greengard; M Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes.

Authors:  P F Méry; S M Lohmann; U Walter; R Fischmeister
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.

Authors:  E Butt; D Pöhler; H G Genieser; J P Huggins; B Bucher
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 4.  A molecular description of nerve terminal function.

Authors:  L F Reichardt; R B Kelly
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

5.  Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions.

Authors:  B R Kwak; M M Hermans; H R De Jonge; S M Lohmann; H J Jongsma; M Chanson
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

6.  Gö 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro.

Authors:  K A Qatsha; C Rudolph; D Marmé; C Schächtele; W S May
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.

Authors:  T Markert; A B Vaandrager; S Gambaryan; D Pöhler; C Häusler; U Walter; H R De Jonge; T Jarchau; S M Lohmann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Frozen tissue sections as an experimental system to reveal specific binding sites for the regulatory subunit of type II cAMP-dependent protein kinase in neurons.

Authors:  P Miller; U Walter; W E Theurkauf; R B Vallee; P De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum.

Authors:  D J Schlichter; J A Detre; D W Aswad; B Chehrazi; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.

Authors:  M Sandberg; E Butt; C Nolte; L Fischer; M Halbrügge; J Beltman; T Jahnsen; H G Genieser; B Jastorff; U Walter
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.